Skip to main content
. 2003 Oct 1;73(5):1157–1161. doi: 10.1086/378819

Table A.

Pathogenic Missense Mutations Found in the hMSH2 Gene[Note]

Nucleotide Position in ORF ESE Exon Codon Nucleotide Nucleotide Change Consequence Type of Amino Acid Substitutiona Geographic Origin Family ID Reference
4 0 1 2 4 G→A Ala→Thr C None specified Myriad et al.
182 1 1 61 182 A→C Gln→Pro C Western Europe Myriad et al.
308 1 2 103 308 A→G Tyr→Cys R None specified Myriad et al.
319 0 2 107 319 G→C Ala→Prol C Czech Republic PT523 A. Krepelova (unpublished)
380 0 3 127 380 A→G Asn→Ser C None specified Myriad et al.
380 0 3 127 380 A→G Asn→Ser C Africa Myriad et al.
380 0 3 127 380 A→G Asn→Ser C Africa Myriad et al.
380 0 3 127 380 A→G Asn→Ser C None specified Myriad et al.
380 0 3 127 380 A→G Asn→Ser C None specified Myriad et al.
435 1 3 145 435 T→G Ile→Met C Czech Republic Patient 338 A. Krepelova (unpublished)
435 1 3 145 435 T→G Ile→Met C None specified A. M. Deffenbaugh et al. (unpublished)
435 1 3 145 435 T→G Ile→Met C Western European Myriad et al.
446 0 3 149 446 G→A Gly→Asp R None specified A. M. Deffenbaugh et al. (unpublished)
505 1 3 169 505 A→G Ile→Valb C Asia A. M. Deffenbaugh et al. (unpublished)
593 1 3 198 593 GAA→GGA Glu→Gly R Sweden 199 Unpublished
595 0 3 199 595 T→C Cys→Arg R Hong Kong [Turcot] Yuen et al., Am J Pathol 153:1181–1188 (1998)
742 0 4 248 742 A→G Lys→Glu C Western Europe Myriad et al.
792 1 4 264 792 G→C Gln→His R Western Europe Myriad et al.
806 1 5 269 806 C→T Ser→Leu R Latin America/Caribbean A. M. Deffenbaugh et al. (unpublished)
815 1 5 272 815 C→T Ala→Val C None specified 0108 MDACCc
913 1 5 305 913 G→A Ala→Thr C Netherlands NL-38 Wijnen et al. (unpublished)
965 1 6 322 965 G→Ab Gly→Asp C Russia 1 Maliaka et al. Hum Genet 97:251–255 (1996)
965 1 6 322 965 G→Ab Gly→Asp C Germany 186 Brieger et al. Clinical Chemistry 45: 1564–1567 (1999)
965 1 6 322 965 G→Ab Gly→Asp C United States 0205 MDACCc
997 0 6 333 997 T→C Cys→Arg R Nigeria 114-I-OL A. de la Chapelle et al. (unpublished)
998 0 6 333 998 G→A Cys→Tyr R Australia IMS5 S. E. Bennett (unpublished)
1012 1 6 338 1012 G→A Gly→Arg R None specified A. M. Deffenbaugh et al. (unpublished)
1082 0 7 361 1082 A→G Arg→Ser R Western Europe Myriad et al.
1319 1 8 440 1319 T→C Leu→Pro R Lithuania O3 E. Avizienyte et al. (unpublished)
1508 0 9 503 1508 T→C Leu→Pro R None specified Myriad et al.
1516 1 10 506 1516 G→T Asp→Tyr R Korea SNU-YC13 Han et al., J. Natl. Cancer Inst. 88: 1317–1319 (1996)
1571 1 10 524 1571 G→C Arg→Pro R None specified Patient 2774 with ovarian cancer Orth et al., Cold Spring Harbor Symp Quant Biol LIX: 349 (1994)
1600 1 10 534 1600 C→T Arg→Cys R United States 3080 MDACCc
1774 1 12 592 1774 A→G Met→Val C None specified Myriad et al.
1807 0 12 603 1807 G→A Asp→Asn R Finland Patient 138 Salovaara et al., J Clin Oncol 18: 2193–2200 (2000)
1864 0 12 622 1864 C→A Missense R Argentina CRE001 Chialina et al. (unpublished)
1865 0 12 622 1865 C→T Pro→Leu R New Zealand J Liu et al., Cancer Res. 54: 4590–4594 (1994)
1906 1 12 636 1906 G→Cb Ala→Pro C France CHI-S6351 B. Bressac-de Paillerets, unpublished
1906 1 12 636 1906 G→Cb Ala→Pro C United States 54 A. de la Chapelle (unpublished)
1906 1 12 636 1906 G→C Ala→Pro C Ashkenazi Jewish MONO7 (y) Yuan et al. J Med Genet 36:790–793 (1999)
1906 1 12 636 1906 G→C Ala→Pro C None specified Myriad et al.
2090 0 13 697 2090 G→T Cys→Phe R Germany 56 Raedle et al. Gastroenterology 116:489A (1999)
2090 0 13 697 2090 G→T Cys→Phe R Germany 62 Wehner et al., Hum Mut 10:241–244 (1997)
2164 1 13 722 2164 G→A Val→Ile R United States 0024 MDACCc
2251 0 14 751 2251 G→A Gly→Arg R France BIL-IGR1924 B. Bressac-de Paillerets
2500 0 15 834 2500 G→A Ala→Thr C Netherlands NL57 J. T. Wijnen et al. (unpublished)
2714 1 16 905 2714 C→G Thr→Arg R United Kingdom C015 Froggatt et al., J. Med. Genet. 33:726–730 (1996)
2714 1 16 905 2714 C→T Thr→Ile R Central/eastern Europe Myriad et al.
2790 0 16 930 2790 A→Gb Ile→Met C Spain GE008 P. Hutter (unpublished) (1999)

Note.— The table enlists missense mutations from the HNPCC mutation database (accessed March 2003) and mutation data obtained by M.L.F. at The University of Texas M. D. Anderson Cancer Center (MDACC).

a

C = conservative; R = radical.

b

Of unknown pathogenicity.

c

The University of Texas M. D. Anderson Cancer Center.